OFEV® (nintedanib) time to face IPF head on Progression waits for no one Document ID: PC-ZA-102061 13/06/2023 Author: Boehringer Ingelheim Start treating a broader range of ILD patients RELATED CONTENT PC-ZA-102061 Production date: June 2023
